-
Investment type
-
Equity / Ordinary Shares, par value GBP 0.05 per share (the "Shares")
-
Latest Disclosed Shares Owned
-
6,644,841 shares
-
Security Ownership %
-
4.7%
Redmile Group, LLC ownership in Silence Therapeutics plc Ordinary Shares, par value GBP 0.05 per share (the "Shares")
15 May 2025 - Redmile Group, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,644,841 shares of Silence Therapeutics plc Ordinary Shares, par value GBP 0.05 per share (the "Shares").
This represents 4.7% ownership of the company.
In their previous filing dated 14 Feb 2025, Redmile Group, LLC had reported owning 7,197,951 shares, indicating a decrease of +7.7%.
.